Value of unenhanced magnetic resonance imaging (MRI) with diffusion-weighted imaging for detection of primary small (≤20 mm) solid pancreatic tumours and prediction of pancreatic ductal adenocarcinoma
Clinical Radiology Aug 11, 2017
Park HJ, et al. – This study was undertaken to investigate the diagnostic performance of unenhanced magnetic resonance imaging (MRI) with diffusion–weighted imaging (DWI; NonMRI) for the detection of primary small pancreatic solid tumours and prediction of pancreatic ductal adenocarcinoma (PDAC) in comparison with pancreatic computed tomography (CT; PanCT) and pancreatic MRI with magnetic resonance cholangiopancreatography (PanMRI). It was shown that NonMRI showed better performance than PanCT, and competitive performance to PanMRI for the detection of primary small solid pancreatic tumours, and displayed reasonable sensitivity for prediction of PDACs compared with PanCT and PanMRI.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries